FemmePharma, Inc.

FemmePharma, Inc. is a privately held women's healthcare company with a focus on the ignored diseases of women.
Some of the areas of therapeutic focus include: endometriosis, benign diseases of the breast, urinary incontinence, and gynecologic oncology. The Company has intellectual property which includes a patented platform drug delivery technology with application to a variety of drug classes and to diseases and disorders of women. This broad patent includes 33 claims ( both utility and formulation).

Activity:

- Licensing & Business Development

Product / Technology type(s) covered:

- Drug delivery
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Oncology
- Reproductive Health
- Women's Health

Markets Covered

a. HeadQuarter:

b. Continent(s) active: North America

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded:

Partners / Alliances: Femme Pharma has developed a strategic partner to market selected products in the U.S. NERILYN Pharmaceuticals will provide marketing support to FemmePharma by using its women's healthcare sales force to promote selected products. NERILYN specializes in the women's disorders and diseases, including problems associated with pregnancy.